ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

BENJAMIN BETANCOURT M.D.

FERNADEZ JUNCOS AVE. 1501 SUITE 401 BETANCOURT BUILDING

Santurce | Puerto Rico | 00910

(787) 728-7240

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,393Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 194

$536K Total Retail Price of All Prescriptions

Rank: 43 out of 194

654 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 13,877 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $36 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
CARVEDILOL 977 873 1 8
SIMVASTATIN 662 567 2 1
LOSARTAN POTASSIUM 626 567 3 3
RAMIPRIL 562 470 4 33
TORSEMIDE 476 428 5 110
BISOPROLOL-HYDROCHLOROTHIAZIDE 452 386 6 49
METFORMIN HCL 399 360 7 9
CLOPIDOGREL 384 332 8 16
TRIAMTERENE-HCTZ 365 303 9 67
LOSARTAN-HYDROCHLOROTHIAZIDE 364 337 10 5
PLAVIX 356 317 11 18
AMLODIPINE BESYLATE 345 325 12 2
CLONIDINE HCL 342 302 13 45
DIGOXIN 270 239 14 26
ISOSORBIDE MONONITRATE ER 266 248 15 12
ATENOLOL 253 240 16 7
METOPROLOL SUCCINATE 248 214 17 4
TERAZOSIN HCL 238 233 18 75
FUROSEMIDE 233 216 19 14
SYNTHROID 230 219 20 17
ENALAPRIL MALEATE 203 186 21 6
CARTIA XT 201 189 10 22 80
METOPROLOL TARTRATE 194 176 23 15
ATORVASTATIN CALCIUM 191 173 24 10
GABAPENTIN 174 159 25 21
FAMOTIDINE 174 158 25 55
PRAVASTATIN SODIUM 167 157 27 25
DILTIAZEM 24HR CD 160 140 28 46
WARFARIN SODIUM 157 141 29 28
RANITIDINE HCL 154 145 30 22
LEVOTHYROXINE SODIUM 143 127 31 20
OMEPRAZOLE 142 130 32 23
CRESTOR 137 112 33 27
GLIMEPIRIDE 133 117 34 29
FOSINOPRIL SODIUM 130 127 35 71
METOLAZONE 119 113 36 104
SPIRONOLACTONE 107 107 37 37
TAMSULOSIN HCL 102 94 38 62
ASPIRIN EC 101 95 39 24
EVISTA 96 96 40 83
AMIODARONE HCL 92 87 41 60
IRBESARTAN 86 70 42 31
VERAPAMIL ER 82 78 43 34
DIOVAN 81 59 44 32
PANTOPRAZOLE SODIUM 77 67 45 44
DIPYRIDAMOLE 77 74 R 45 105
LISINOPRIL 76 76 47 11
ZOLPIDEM TARTRATE 72 66 48 42
NIFEDIPINE ER 70 70 49 47
DOXAZOSIN MESYLATE 67 58 50 19
TRAMADOL HCL 66 63 51 95
DILTIAZEM ER 66 58 51 97
DILTIAZEM 24HR ER 64 54 53 91
LANSOPRAZOLE 63 49 54 79
EFFIENT 56 53 55 136
AVAPRO 55 45 56 41
GLYBURIDE 55 55 R 56 94
NAMENDA 54 54 58 109
COUMADIN 54 54 58 38
ENALAPRIL-HYDROCHLOROTHIAZIDE 53 41 60 111
BUSPIRONE HCL 53 49 60 165
ATACAND 52 38 62 68
BISOPROLOL FUMARATE 51 47 63 118
ATENOLOL-CHLORTHALIDONE 50 46 64 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.